Working together

As part of the IDDO platform, WWARN works in partnership with multiple organisations to share knowledge, expertise and understanding on the efficacy of malaria drugs.


Collaborator network

We collaborate with over 282 research institutes and organisations from across the world.

Discover our collaborating partners.

Study groups

The WWARN network encourages our research partners to undertake individual patient data meta-analyses to answer specific research questions about malaria drug resistance. Join one of our Study Groups
Malaria in Pregnancy Treatment Efficacy Study Group

Assessing the efficacy of a range of antimalarials used for the treatment of P. falciparum malaria in all trimesters of pregnancy in Africa and Asia
The MiP Treatment Efficacy Study Group was formed in July 2016, with a call to interested researchers with relevant data sets.

Correlation between K13 mutations and clinical phenotype Study Group

A pooled analysis on the relationship between K13 molecular marker and parasite clearance data. The Study Group closed to new participants in December 2015. The analysis was completed between 2016–2018 and the group published in January 2019. WWARN K13 Genotype-Phenotype Study Group. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis. BMC Medicine. January 17, 2019.

ACT Malaria and Malnutrition Study Group

A pooled analysis that assessed the effect of various nutritional indicators in treatment outcome in children aged 6-59 months treated with artemisinin based combination therapies for uncomplicated P. falciparum malaria.
This group has published a first manuscript: Complex interactions between malaria and malnutrition: a systematic literature review. Das D et al. BMC Medicine. 2018 Oct 29;16(1):186. Read this news article summarising the results.

Scientific groups

Our Scientific Groups work collaboratively to explore the multiple research areas of antimalarial drug resistance and drug efficacy. Learn more about our Clinical, Malaria in Pregnancy, In vitro, Pharmacology, Molecular and Medicine Quality groups.

Sharing and pooling data is supporting global efforts to curb the spread of malaria drug resistance. See examples of our data sharing tools, and how you can benefit from joining our data sharing efforts.

Partnerships play a critical role in WWARN’s efforts to combat antimalarial drug resistance. Find out more about the international research projects we are supporting.